Richard Waldron

Mr. Waldron has extensive experience in the financing and executive operations of biotechnology companies. He has served as the Chief Financial Officer of three publicly traded companies, successfully raising capital for all three and executing the merger of one of them. Prior to working in the industry Mr. Waldron served as a senior health care banker, executing public and private financings and strategically significant transactions for clients including Genzyme and Genentech. He initiated the health care sector banking practice at Cowen & Company. He graduated with honors from Harvard Business School, and magna cum laude from Princeton University.